Back to Search
Start Over
Did our pharmacological strategy for COVID-19 fail?
- Source :
- Pharmacology Research & Perspectives, Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
- Publication Year :
- 2021
- Publisher :
- UK : John Wiley & Sons, Ltd, 2021.
-
Abstract
- Refereed/Peer-reviewed
- Subjects :
- 2019-20 coronavirus outbreak
renin angiotensin system
Angiotensin Receptor Antagonists
Coronavirus disease 2019 (COVID-19)
SARS-CoV-2
business.industry
cognitive bias
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19
Angiotensin-Converting Enzyme Inhibitors
RM1-950
Virology
statins
0304 Medicinal and Biomolecular Chemistry, 1115 Pharmacology and Pharmaceutical Sciences
Editorial
Neurology
COVID‐19
Renin–angiotensin system
Humans
Medicine
observational study
Therapeutics. Pharmacology
General Pharmacology, Toxicology and Pharmaceutics
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Pharmacology Research & Perspectives, Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
- Accession number :
- edsair.doi.dedup.....6634e132f068310a83dd54b7d1aeac04